Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

[1]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.

[2]  J. R. Wilson,et al.  Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array , 2016, British Journal of Cancer.

[3]  Manolis Kellis,et al.  HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease , 2015, Nucleic Acids Res..

[4]  Peter Kraft,et al.  A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[5]  J. Witte,et al.  Strategies for Imputing and Analyzing Rare Variants in Association Studies. , 2015, Trends in genetics : TIG.

[6]  N. Makridakis,et al.  Somatic Mutations in Catalytic Core of POLK Reported in Prostate Cancer Alter Translesion DNA Synthesis , 2015, Human mutation.

[7]  Dennis J. Hazelett,et al.  Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans , 2015, Human molecular genetics.

[8]  G. Kempermann.  Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[9]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[10]  Lawrence D. True,et al.  Integrative Clinical Genomics of Advanced Prostate Cancer , 2015, Cell.

[11]  Bernard Rachet,et al.  40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study , 2015, The Lancet.

[12]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[13]  Peter Kraft,et al.  A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer , 2014, Nature Genetics.

[14]  William Wheeler,et al.  Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer , 2014, Nature Genetics.

[15]  K. Czene,et al.  The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[16]  R. Eeles,et al.  Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease , 2014, British Journal of Cancer.

[17]  Yang Xu,et al.  MutS Homologue hMSH5: Recombinational DSB Repair and Non-Synonymous Polymorphic Variants , 2013, PloS one.

[18]  Iuliana Ionita-Laza,et al.  Sequence kernel association tests for the combined effect of rare and common variants. , 2013, American journal of human genetics.

[19]  R. Eeles,et al.  Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  C. Her,et al.  Send Orders of Reprints at Reprints@benthamscience.net Muts Homologues Hmsh4 and Hmsh5: Genetic Variations, Functions, and Implications in Human Diseases , 2022 .

[21]  A Jakubowska,et al.  An inherited NBN mutation is associated with poor prognosis prostate cancer , 2012, British Journal of Cancer.

[22]  Peter Kraft,et al.  Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array , 2013, Nature Genetics.

[23]  Bo Dai,et al.  Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4 , 2012, Nature Genetics.

[24]  N. Makridakis,et al.  Translesion DNA Polymerases and Cancer , 2012, Front. Gene..

[25]  M. Rieder,et al.  Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. , 2012, American journal of human genetics.

[26]  Kai Wang,et al.  wANNOVAR: annotating genetic variants for personal genomes via the web , 2012, Journal of Medical Genetics.

[27]  Xinru Wang,et al.  Common variants in mismatch repair genes associated with increased risk of sperm DNA damage and male infertility , 2012, BMC Medicine.

[28]  E. Génin,et al.  Lung cancer and DNA repair genes: multilevel association analysis from the International Lung Cancer Consortium. , 2012, Carcinogenesis.

[29]  D. Easton,et al.  Germline BRCA1 mutations increase prostate cancer risk , 2012, British Journal of Cancer.

[30]  A. D’Andrea,et al.  A DNA Repair Pathway–Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based Chemotherapy , 2012, Journal of the National Cancer Institute.

[31]  D. Easton,et al.  BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients , 2011, British Journal of Cancer.

[32]  Xihong Lin,et al.  Rare-variant association testing for sequencing data with the sequence kernel association test. , 2011, American journal of human genetics.

[33]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[34]  M. Rubin,et al.  Predisposition for TMPRSS2-ERG Fusion in Prostate Cancer by Variants in DNA Repair Genes , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[35]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[36]  J. Morrison,et al.  A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer , 2009, British Journal of Cancer.

[37]  Christopher I Amos,et al.  Common 5p15.33 and 6p21.33 variants influence lung cancer risk , 2008, Nature Genetics.

[38]  Tomas Lindahl,et al.  Human DNA repair genes, 2005. , 2005, Mutation research.

[39]  David I. Smith,et al.  Mutations in CHEK2 associated with prostate cancer risk. , 2003, American journal of human genetics.

[40]  Richard D. Wood,et al.  Human DNA Repair Genes , 2001, Science.

[41]  F. Hamdy,et al.  Screening for Prostate Cancer , 2006 .

[42]  Ali Amin Al Olama,et al.  The genetic epidemiology of prostate cancer and its clinical implications , 2014, Nature Reviews Urology.

[43]  O. Delaneau,et al.  Supplementary Information for ‘ Improved whole chromosome phasing for disease and population genetic studies ’ , 2012 .